Staging classification of aortic stenosis based on the extent of cardiac damage

Philippe Généreux1,2,3, Philippe Pibarot4, Björn Redfors1,5

  • 1Clinical Trials Center, Cardiovascular Research Foundation, New York, NY, USA.

European Heart Journal
|October 12, 2017
PubMed

Insights

A new staging system for extravalvular cardiac damage in severe aortic stenosis (AS) predicts mortality after aortic valve replacement (AVR). Increased damage stages correlate with higher mortality risk, improving risk stratification for patients undergoing AVR.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Echocardiography

Background:

  • Risk stratification for aortic valve replacement (AVR) in severe aortic stenosis (AS) traditionally relies on valve-related factors, symptoms, and comorbidities.
  • Extravalvular cardiac damage is increasingly recognized as a significant factor influencing outcomes after AVR.

Purpose of the Study:

  • To evaluate the prognostic impact of a novel staging classification for extravalvular cardiac damage in severe AS patients undergoing AVR.
  • To determine if this staging system improves risk stratification for clinical outcomes post-AVR.

Main Methods:

  • A cohort of 1661 patients with severe AS from the PARTNER 2 trials were retrospectively staged (Stage 0-4) based on echocardiographic evidence of extravalvular cardiac damage prior to AVR.
  • One-year mortality was analyzed using Kaplan-Meier methods and multivariable Cox proportional hazards models.

Main Results:

  • The study identified distinct stages of cardiac damage: Stage 0 (no damage), Stage 1 (left ventricular), Stage 2 (left atrial/mitral), Stage 3 (pulmonary/tricuspid), and Stage 4 (right ventricular).
  • One-year mortality significantly increased with each stage of damage, ranging from 4.4% in Stage 0 to 24.5% in Stage 4 (Ptrend < 0.0001).
  • The extent of cardiac damage was independently associated with increased mortality after AVR (HR 1.46 per stage increment).

Conclusions:

  • A newly described staging classification objectively characterizes the extent of cardiac damage associated with AS.
  • This staging system has significant prognostic implications for predicting clinical outcomes after AVR, offering enhanced risk stratification.
Abstract

Related Concept Videos

Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
456
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
626
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
300
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
398
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
795
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
827